Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers

被引:414
|
作者
Rege, BD
Kao, JPY
Polli, JE [1 ]
机构
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, Baltimore, MD 21201 USA
关键词
nonionic surfactants; transporters; P-glycoprotein (P-gp); human intestinal peptide transporter (hPepT-1); monocarboxylic acid transporter (MCT);
D O I
10.1016/S0928-0987(02)00055-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objectives of this study were (1) to investigate the transporter inhibition activity of three nonionic surfactants on P-glycoprotein, the human intestinal peptide transporter, and the monocarboxylic acid transporter in Caco-2 cell monolayers, and (2) to evaluate the role of membrane fluidity and protein kinase C in surfactant-induced transporter inhibition. All three surfactants inhibited P-glycoprotein (P-gp). Over a range from 0 to 1 mM, Tween 80 and Cremophor EL increased apical-to-basolateral permeability (AP-BL) and decreased basolateral-to-apical (BL-AP) permeability of the P-gp substrate rhodamine 123. Vitamin E TPGS's effect was equally large, but essentially only reduced the BL-AP permeability of rhodamine 123, and did so at a vitamin E TPGS concentration of only 0.025 mM. These P-gp inhibition effects would appear to be related to these excipients' modulation of membrane fluidity, where Tween 80 and Cremophor EL fluidized cell lipid bilayers, while vitamin E TPGS rigidized lipid bilayers. However, among the three surfactants, only Tween 80 inhibited the peptide transporter, as measured by glycyl sarcosine permeability. Likewise, only Cremophor EL inhibited the monocarboxylic acid transporter, as measured by benzoic acid permeability. Nevertheless, at least one of these three surfactants inhibited each P-gp, the human intestinal peptide transporter, and the monocarboxylic acid transporter. A common functional feature of these three surfactants was their ability to modulate fluidity, although results indicate that even strong membrane fluidity modulation alone was not sufficient to reduce transporter activity. N-octyl glucoside, a nonionic surfactant that did not modulate membrane fluidity, did not affect transporter functioning. Protein kinase C inhibitors failed to affect rhodamine 123 and glycyl sarcosine permeability, suggesting protein kinase C inhibition was not the mechanism of transporter inhibition. These results suggest that surfactants can inhibit multiple transporters but that changes in membrane fluidity may not be a generalized mechanism to reduce transporter activity. (C) 2002 Elsevier Science B V All rights reserved.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 25 条
  • [1] Transport characteristics of isorhamnetin across intestinal Caco-2 cell monolayers and the effects of transporters on it
    Duan, Jingze
    Xie, Yan
    Luo, Huilin
    Li, Guowen
    Wu, Tao
    Zhang, Tong
    FOOD AND CHEMICAL TOXICOLOGY, 2014, 66 : 313 - 320
  • [2] Carrier-mediated γ-aminobutyric acid transport across the basolateral membrane of human intestinal Caco-2 cell monolayers
    Nielsen, Carsten Uhd
    Carstensen, Mette
    Brodin, Birger
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (02) : 458 - 462
  • [3] The effects of intralaboratory modifications to media composition and cell source on the expression of pharmaceutically relevant transporters and metabolizing genes in the Caco-2 cell line
    Roth, Wyatt J.
    Lindley, David J.
    Carl, Stephen M.
    Knipp, Gregory T.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (10) : 3962 - 3978
  • [4] The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics
    Y. Sambuy
    I. De Angelis
    G. Ranaldi
    M. L. Scarino
    A. Stammati
    F. Zucco
    Cell Biology and Toxicology, 2005, 21 : 1 - 26
  • [5] The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics
    Sambuy, Y
    Angelis, I
    Ranaldi, G
    Scarino, ML
    Stammati, A
    Zucco, F
    CELL BIOLOGY AND TOXICOLOGY, 2005, 21 (01) : 1 - 26
  • [6] P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants
    Jakobsen, Sebastian
    Ge, Lorraine Gaenaelle
    Pedersen, Maria
    Griffin, Brendan T.
    Holm, Rene
    Nielsen, Carsten Uhd
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 624
  • [7] Human enteroid monolayers as a potential alternative for Ussing chamber and Caco-2 monolayers to study passive permeability and drug efflux
    Streekstra, Eva J.
    Keuper-Navis, Marit
    van den Heuvel, Jeroen J. M. W.
    van den Broek, Petra
    Stommel, Martijn W. J.
    Bervoets, Sander
    O'Gorman, Luke
    Greupink, Rick
    Russel, Frans G. M.
    van de Steeg, Evita
    de Wildt, Saskia N.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 201
  • [8] Titanium dioxide nanoparticles translocate through differentiated Caco-2 cell monolayers, without disrupting the barrier functionality or inducing genotoxic damage
    Vila, Laura
    Garcia-Rodriguez, Alba
    Marcos, Ricard
    Hernandez, Alba
    JOURNAL OF APPLIED TOXICOLOGY, 2018, 38 (09) : 1195 - 1205
  • [9] Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: Interaction with the transporters on Caco-2 cells
    Katragadda, Suresh
    Jain, Ritesh
    Kwatra, Deep
    Hariharan, Sudharshan
    Mitra, Ashim K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 362 (1-2) : 93 - 101
  • [10] Impact of Endogenous Esterase Activity on In Vitro P-Glycoprotein Profiling of Dabigatran Etexilate in Caco-2 Monolayers
    Ishiguro, Naoki
    Kishimoto, Wataru
    Volz, Astrid
    Ludwig-Schwellinger, Eva
    Ebner, Thomas
    Schaefer, Olaf
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (02) : 250 - 256